Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ETN vs GSK✓SelectedUSD · GSKETN vs GSK performance historyLatest closeAs of+0.07%11/17
Stock and ETF performance explorer

ETN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+53.5%
GSK return
+58.9%
Excess return
-5.4%
Maximum drawdown
-34.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.1%-2.3%+2.4%-0.1%
7D-4.8%-3.0%-1.8%-5.1%
30D-13.6%+0.4%-13.9%-13.4%
3M-25.7%-1.2%-24.6%-25.5%
6M-15.1%+0.9%-16.1%-15.1%
YTD+7.1%+4.0%+3.1%+7.6%
1Y-0.5%+7.3%-7.8%-0.1%
3Y+53.5%+57.1%-3.6%+53.3%
All+53.5%+58.9%-5.4%+53.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling